Serious Adverse Events

Slide 17 of 21

Notes:

Increase in SAEs seen as duration increases (also seen with increased RBV dose for 24 wk groups)

Note: these are ALL SAEs (if look just at those considered ërelatedí the numbers areÖ.1% 3% 4% 3%)

NOTE: slide will be modified to show the ërelatedí numbers also